• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • MANUFACTURERS
  • HEADHUNTERS
  • COMPANIES

SPINEMarketGroup

Spine Industry News

  • HOME
  • 2026
  • 2025
  • 2024
  • BROCHURES
  • ARTICLES
  • PRODUCT LIBRARY

EXALTA Secures EU-MDR Certification for Titanium Compression Screws, Expanding Access to Advanced Trauma Solutions

October 15, 2025 By SPINEMarketGroup

BETHLEHEM, PA, UNITED STATES, October 15, 2025 /EINPresswire.com/ — EXALTA Group, a global leader in the development and manufacturing of integrated OEM solutions for mission-critical medical devices, today announced it has obtained European Medical Device Regulation (EU-MDR) certification for its full range of headed and headless titanium compression screws used in trauma and reconstructive surgery.

This certification enables EXALTA’s OEM partners to commercialize these proven platforms across Europe, providing surgeons and patients broader access to high-performance fixation systems. Developed to meet the demands of modern trauma and reconstructive procedures, the portfolio covers indications including bone reconstruction, osteotomy, arthrodesis, joint fusion, and fracture fixation.

EXALTA’s compression screw systems combine strength, precision, and simplicity. Offered in diameters from 1.5 mm to 9.0 mm, and available in headed or headless configurations, they are manufactured in titanium with short, long, or full thread options. A cannulated design ensures accurate K-wire insertion, while self-drilling and self-tapping features streamline placement. Supplied in sterile or non-sterile packaging, the systems deliver consistent performance and ease of use in diverse surgical settings.

“Achieving EU-MDR certification for our compression screw systems underscores EXALTA’s commitment to regulatory excellence and patient safety,” said Lisa Boyle, Vice President of Regulatory Affairs at EXALTA Group. “This certification validates the quality and performance of our devices and accelerates our partners’ ability to bring these technologies to European surgeons and patients faster. Our teams continue to deliver on EXALTA’s promise of combining robust compliance with speed-to-market.”

While EXALTA’s technology platforms are exclusively marketed under its customers’ brands, the EXALTA team will make its debut at the Orthopaedic Trauma Association (OTA) Annual Meeting, Booth #129, October 15–18 in Phoenix, AZ, to connect with OEM partners and explore new opportunities to fast-track innovation and expand global access to advanced trauma solutions.

About EXALTA Group
With operations across multiple continents, EXALTA Group is a global solutions provider for the MedTech industry. Through its Manufacturing Solutions and Integrated OEM Solutions business units, the company supports leading OEMs in delivering breakthrough medical devices that improve patient outcomes worldwide. Learn more at exalta.com

Francois Samson
EXALTA
+1 901-647-1304
fsamson@exalta.com

Legal Disclaimer:

EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Related Posts:

  • EXALTA Group Receives FDA 510(k) Clearance for New…
  • We are proud to announce that EXALTA will once again…
  • Introducing EXALTA: A Bold New Brand Unifying…

Filed Under: FDA APPROVED, NEWS Tagged With: 2025

Primary Sidebar

PLATINUM SPONSORS

EXALTA 2LOGO-min
GLOBAL biomedica
NORMED newLOGO-min
GENESYS SPINE
SPINEGUARD2025
Dymicron 2
GSMEDICAL2025
spinewaygroup
RUTHLESS SPINE
RUDISHAUER
NGMEDICAL
LfC
ispine
CENTINEL SPINE
TSUNAMI MEDICAL
syntropiq logo
A-SPINE
L&Kmodelo log

POPULAR POST LAST 90 DAYS

  • Globus Medical: Stronger in Spine, but Could DePuy…
  • BROCHURES
  • DePuy Synthes for Sale: Who Could Actually Buy the…
  • Highridge Medical CEO Departure: Spine’s…
  • Boston Scientific Puts $1.5 Billion on MiRus: Why…
  • Globus Medical: Strong Q1, Weak Stock Reaction — Is…
  • (2025 Update): Market, Leading FDA-Approved Devices,…
  • (UPDATED 2025): 6 Artificial Cervical Discs You’ll…
  • Strong Surgery, Soft Quarter: ATEC and the Cost of…
  • Modular Pedicle Screws: When Adaptability Becomes…
  • COMPANIES
  • Autonomous Pedicle Screw Placement: Is Spine…
  • (UPDATED 2026) More Than 100 Options, No Single…
  • The Giant Next Door: Is Mindray Spine’s Next…
  • Cervical Fusion Implant Denials: Why Spine Societies…
  • Hospital Access Is Gone. What Comes Next for Spine…
  • VB Spine Announces VB Spine Solutions, a…
  • Top 60+ Minimally Invasive Sacroiliac Joint Fusion…
  • What Is Medtronic’s PILAR™ Technique?
  • Sublaminar Bands in Spine Surgery: Why This Small…
  • Johnson & Johnson Explores Potential $20B Sale…
  • Percutaneous MIS Spine Systems: Why Adoption Still…
  • PRODUCT LIBRARY
  • Globus Medical Reports First Quarter 2026 Results
  • L&K Spine Performs First U.S. Deformity Case…
  • Orthopedics Is Moving Into Pain. Zimmer and Globus…
  • VB Spine Signs Master Agreement with Apolo Medica
  • ProFlex Spine: Can a Nitinol Implant Crack…
  • Orthofix Discontinues M6-C™ and M6-L™ Artificial…
  • Who Is PAULA, and Why Should Every Deformity Surgeon…
  • LAST 5 VIDEOS PUBLISHED

    1. Mighty Oak: Acorn 3D™
    2. Syntropiq: Lyra
    3. ATEC Spine: SafeOp®
    4. REACH Medical: Expandable PLIF/TLIF Cage
    5. Expanding Innovations: X-PAC®TLIF 

    Footer

    Contact us:

    spinemarketgroup@gmail.com info@thespinemarketgroup.com

    • LinkedIn
    • Twitter
    • YouTube

    PRIVACY POLICY

    • Legal
    • PRODUCT LIBRARY

    Copyright © 2026 · SPINEMarketGroup